Choi, Kyung Mook

Department of Endocrinology, Korea University Guro (MD, PhD)

E-Mail

medica7@gmail.com, medica7@korea.ac.kr

Research content

• Clinical utility evaluation based on cohort
• Discovery of new biomarkers
• Collaborative research on therapeutic candidates

Representative paper

1. Song E, Hwang SY, Park MJ, Jang A, Kim KJ, Yu JH, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi KM*. Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study. Metabolism 148:155678, 2023




2. Roh E, Hwang SY, Yoo HJ, Baik SH, Lee JH, Son SJ, Kim HJ, Park YS, Lee SG, Cho BL, Jang HC, Kim BJ, Kim MJ, Won CW, Choi KM*. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study. Hepatol Int 2022 Jun; 16(3):545-554




3. Kim JA, Lee JS, Chung HS, Roh E, Lee Y-B, Hong S-H, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi KM*. Impact of visit-to-visit fasting plasma glucose variability on the development of type 2 diabetes. A Nationwide population-based cohort study. Diabetes Care. 2018 Dec;41(12):2610-2616




4. Nam GE, Kim SM, Han K, Km NH, Chung HS, Kim JW, Han B, Cho SJ, Yu JH, Park YG, Choi KM*. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study. PLoS Medicine. 2018 Aug; 15(8):1002640




5. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM*. The relationship between sarcopenia and non-alcoholic fatty liver disease (NAFLD): The Korean Sarcopenic Obesity Study (KSOS). Hepatology. 2014 May;59(5):1772-8